TELO Latest Press Releases

-- June 15, 2026 --

Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Type 2 Diabetes Model ACCESS Newswire 8:00 AM

-- May 20, 2026 --

Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease ACCESS Newswire 8:00 AM

-- April 30, 2026 --

Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer ACCESS Newswire 8:00 AM

-- April 24, 2026 --

Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn) ACCESS Newswire 9:00 AM

-- March 31, 2026 --

Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) in Advanced and Metastatic Triple-Negative Breast Cancer ACCESS Newswire 8:05 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software